Date Filed | Type | Description |
10/04/2023 |
4
| Dummer Wolfgang (Chief Medical Officer) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 200,000 options to buy
@ $11.37, valued at
$2.3M
|
|
10/04/2023 |
3
| Dummer Wolfgang (Chief Medical Officer) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC. |
04/27/2023 |
3
| Form 3 - Initial statement of beneficial ownership of securities: |
01/05/2023 |
4
| Sandler Andrew Seth (Chief Medical Officer) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 50,000 options to buy
@ $0 |
|
01/05/2023 |
4
| Thompson Peter A. (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/05/2023 |
4
| GOLD MITCHELL (Executive Chairman and CEO) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 350,000 options to buy
@ $0 |
|
01/05/2023 |
4
| Rickey James Paul (See Remarks) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 109,000 options to buy
@ $0 |
|
01/05/2023 |
4
| PENG STANFORD L (See Remarks) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 150,000 options to buy
@ $0 |
|
01/05/2023 |
4
| Topper James N (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/05/2023 |
4
| Drappa Jorn (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/05/2023 |
4
| Hernday Natasha (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/05/2023 |
4
| Peetz Christopher (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/05/2023 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/05/2023 |
4
| Cui Xiangmin (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
09/27/2022 |
4
| Cui Xiangmin (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 639,456 shares
@ $7.35, valued at
$4.7M
Granted 1,360,544 shares
@ $7.35, valued at
$10M
|
|
09/27/2022 |
4
| Decheng Capital China Life Sciences USD Fund III, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 639,456 shares
@ $7.35, valued at
$4.7M
Granted 1,360,544 shares
@ $7.35, valued at
$10M
|
|
08/18/2022 |
4
| Sandler Andrew Seth (Chief Medical Officer) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 160,000 options to buy
@ $8.38, valued at
$1.3M
|
|
08/18/2022 |
3
| Sandler Andrew Seth (Chief Medical Officer) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC. |
07/19/2022 |
4
| Drappa Jorn (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 20,000 options to buy
@ $8.71, valued at
$174.2k
|
|
07/19/2022 |
3
| Drappa Jorn (Director) has filed a Form 3 on ALPINE IMMUNE SCIENCES, INC. |
07/19/2022 |
4
| Form 4 - Statement of changes in beneficial ownership of securities: |
02/15/2022 |
4
| Frazier Life Sciences VIII, L.P. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Bought 112,665 shares
@ $7.1006, valued at
$800k
|
|
01/06/2022 |
4
| PENG STANFORD L (See Remarks) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 215,000 options to buy
@ $0 |
|
01/06/2022 |
4
| GOLD MITCHELL (Executive Chairman and CEO) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 215,000 options to buy
@ $0 |
|
01/06/2022 |
4
| Rickey James Paul (Senior VP and CFO) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 112,500 options to buy
@ $0 |
|
01/04/2022 |
4
| Rickey James Paul (Senior VP and CFO) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Sold 17,013 shares
@ $13.9162, valued at
$236.8k
|
|
01/04/2022 |
4
| Venkatesan Jay (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/04/2022 |
4
| Peetz Christopher (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/04/2022 |
4
| CONWAY ROBERT E (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/04/2022 |
4
| Topper James N (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/04/2022 |
4
| Hernday Natasha (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/04/2022 |
4
| Thompson Peter A. (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
01/04/2022 |
4
| Cui Xiangmin (10% Owner) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Granted 10,000 options to buy
@ $0 |
|
09/27/2021 |
4/A
| Peetz Christopher (Director) has filed a Form 4 on ALPINE IMMUNE SCIENCES, INC.
Txns:
| Bought 1,900 shares
@ $10.17, valued at
$19.3k
|
|
|